| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $20K | -46.6% |
| Cost of Revenue | $26K | -11.3% |
| Gross Profit | -$6K | -178.2% |
| R&D Expense | $733K | +113.1% |
| SG&A Expense | $166K | +9.7% |
| Operating Income | -$2.8M | -10.9% |
| Pre-tax Income | -$2.9M | -17.2% |
| Net Income | -$2.9M | -17.2% |
| EPS (Basic) | -$0.01 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.6M | -6.7% |
| Accounts Receivable | $7K | -36.4% |
| Current Assets | $1.6M | -7.6% |
| Total Assets | $1.6M | -7.6% |
| Current Liabilities | $245K | +199.9% |
| Total Liabilities | $245K | +199.9% |
| Stockholders' Equity | $1.4M | -17.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.3M | -15.4% |
| Financing Cash Flow | $1.2M | -3.3% |
| +0.0% |
| EPS (Diluted) | -$0.01 | +0.0% |